Institutional Ownership Biocryst Pharmaceuticals Inc (BCRX)
This table provides information about the institutional ownership of Biocryst Pharmaceuticals Inc (BCRX). We have compiled data on the 278 institutions that hold shares in the stock, with a total of 172 Million shares, which have been reported (via 13F filing form) to have a value of $1.38 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Parkman Healthcare Partners LLC
Stamford, CT |
Nov 14, 2024 Q3 2024 |
464,048
shares
|
$3.56 Million
0.5% of portfolio
|
Q3 2024
Added 15.88%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2024 Q3 2024 |
460,530
shares
|
$3.53 Million
0.0% of portfolio
|
Q3 2024
Added 6.61%
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
Nov 14, 2024 Q3 2024 |
431,230
shares
|
$3.31 Million
0.0% of portfolio
|
Q3 2024
New holding
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
425,019
shares
|
$3.26 Million
0.0% of portfolio
|
Q3 2024
Added 8.57%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
389,530
shares
|
$2.99 Million
0.0% of portfolio
|
Q3 2024
Reduced 10.02%
|
|
Knott David M Jr
Syosset, NY |
Nov 13, 2024 Q3 2024 |
382,000
shares
|
$2.93 Million
1.02% of portfolio
|
Q3 2024
Added 21.54%
|
|
Rafferty Asset Management, LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
371,034
shares
|
$2.85 Million
0.01% of portfolio
|
Q3 2024
Reduced 20.33%
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Nov 14, 2024 Q3 2024 |
367,514
shares
|
$2.82 Million
0.01% of portfolio
|
Q3 2024
Reduced 50.31%
|
|
Swiss National Bank
Zurich, V8 |
Nov 07, 2024 Q3 2024 |
363,968
shares
|
$2.79 Million
0.0% of portfolio
|
Q1 2024
Reduced 2.54%
|
|
Capital Fund Management S.A.
Paris, I0 |
Nov 13, 2024 Q3 2024 |
357,615
shares
|
$2.74 Million
0.01% of portfolio
|
Q3 2024
Added 44.47%
|
|
Rhumbline Advisers
Boston, MA |
Nov 12, 2024 Q3 2024 |
303,517
shares
|
$2.33 Million
0.0% of portfolio
|
Q3 2024
Reduced 4.75%
|
|
Td Asset Management Inc
|
Nov 01, 2024 Q3 2024 |
302,724
shares
|
$2.32 Million
0.0% of portfolio
|
Q3 2024
Added 25.82%
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Nov 13, 2024 Q3 2024 |
299,152
shares
|
$2.29 Million
0.0% of portfolio
|
Q3 2024
Added 40.72%
|
|
Gsa Capital Partners LLP
London, X0 |
Nov 05, 2024 Q3 2024 |
285,588
shares
|
$2.19 Million
0.16% of portfolio
|
Q3 2024
Reduced 21.51%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
279,143
shares
|
$2.14 Million
0.0% of portfolio
|
Q3 2024
Reduced 12.21%
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2024 Q3 2024 |
275,790
shares
|
$2.12 Million
0.0% of portfolio
|
Q2 2024
Added 16.75%
|
|
Cinctive Capital Management LP
New York, NY |
Nov 14, 2024 Q3 2024 |
273,959
shares
|
$2.1 Million
0.12% of portfolio
|
Q3 2024
New holding
|
|
Jump Financial, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
271,739
shares
|
$2.08 Million
0.05% of portfolio
|
Q3 2024
Added 35.73%
|
|
Legal & General Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
264,884
shares
|
$2.03 Million
0.0% of portfolio
|
Q3 2024
Reduced 5.87%
|
|
Franklin Resources Inc
San Mateo, CA |
Nov 27, 2024 Q3 2024 |
263,748
shares
|
$2.02 Million
0.0% of portfolio
|
Q3 2024
Added 177.75%
|
|
Walleye Capital LLC
Plymouth, MN |
Nov 14, 2024 Q3 2024 |
259,382
shares
|
$1.99 Million
0.0% of portfolio
|
Q3 2024
Added 24.21%
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2024 Q3 2024 |
253,901
shares
|
$1.95 Million
0.0% of portfolio
|
Q3 2024
New holding
|
|
Macquarie Group LTD
Australia, C3 |
Nov 14, 2024 Q3 2024 |
249,495
shares
|
$1.91 Million
0.0% of portfolio
|
Q3 2024
New holding
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2024 Q3 2024 |
234,866
shares
|
$1.8 Million
0.0% of portfolio
|
Q3 2024
Reduced 15.01%
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
229,544
shares
|
$1.76 Million
0.0% of portfolio
|
Q4 2023
Reduced 0.65%
|